These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33479898)

  • 21. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
    J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD80 (B7.1) and CD86 (B7.2) induce EBV-transformed B cell apoptosis through the Fas/FasL pathway.
    Park GB; Kim YS; Lee HK; Cho DH; Kim D; Hur DY
    Int J Oncol; 2013 Nov; 43(5):1531-40. PubMed ID: 24008628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
    Bonardelle D; Benihoud K; Kiger N; Bobé P
    J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege.
    Gregory MS; Repp AC; Holhbaum AM; Saff RR; Marshak-Rothstein A; Ksander BR
    J Immunol; 2002 Sep; 169(5):2727-35. PubMed ID: 12193747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival.
    Xu G; Zhang J
    J Cancer Res Clin Oncol; 2008 Oct; 134(10):1043-9. PubMed ID: 18461366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells.
    Watanabe D; Suda T; Nagata S
    Int Immunol; 1995 Dec; 7(12):1949-56. PubMed ID: 8746564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjögren's syndrome.
    Ishimaru N; Yanagi K; Ogawa K; Suda T; Saito I; Hayashi Y
    J Immunol; 2001 Nov; 167(10):6031-7. PubMed ID: 11698484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.
    Silva DG; Petrovsky N; Socha L; Slattery R; Gatenby P; Charlton B
    J Immunol; 2003 May; 170(10):4996-5002. PubMed ID: 12734343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival.
    Min WP; Gorczynski R; Huang XY; Kushida M; Kim P; Obataki M; Lei J; Suri RM; Cattral MS
    J Immunol; 2000 Jan; 164(1):161-7. PubMed ID: 10605007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fas-ligand-expressing adenovirus-transfected dendritic cells decrease allergen-specific T cells and airway inflammation in a murine model of asthma.
    Chuang YH; Suen JL; Chiang BL
    J Mol Med (Berl); 2006 Jul; 84(7):595-603. PubMed ID: 16565865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis.
    Batteux F; Lores P; Bucchini D; Chiocchia G
    J Immunol; 2000 Feb; 164(4):1681-8. PubMed ID: 10657610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Fas ligand expression of peripheral B-1 cells correlated with CD4
    Mishra R; Panda SK; Sahoo PK; Bal MS; Satapathy AK
    Parasite Immunol; 2017 Apr; 39(4):. PubMed ID: 28208221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA class I molecules is Fas ligand/Fas mediated: evidence for the involvement of p56lck, calcium calmodulin kinase II, and Calcium-independent protein kinase C signaling pathways and for NF-kappaB and NF-AT nuclear translocation.
    Contini P; Ghio M; Merlo A; Poggi A; Indiveri F; Puppo F
    J Immunol; 2005 Dec; 175(11):7244-54. PubMed ID: 16301629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.
    Sinha P; Chornoguz O; Clements VK; Artemenko KA; Zubarev RA; Ostrand-Rosenberg S
    Blood; 2011 May; 117(20):5381-90. PubMed ID: 21450901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
    J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
    Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
    J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression.
    Delgado M; Ganea D
    J Immunol; 2000 Feb; 164(3):1200-10. PubMed ID: 10640731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expression.
    Delgado M; Ganea D
    J Immunol; 2000 Jul; 165(1):114-23. PubMed ID: 10861043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.